Pharmaceutical Package Leaflets Can be Made Easier to Read
This article was originally published in SRA
Catarina Edfjäll, Sonja Pumplün, Julia Hierro and Lisette Vromans outline a strategy for testing leaflets which has been developed through the European Federation of Pharmaceutical Industries and Associations.
You may also be interested in...
After federal agencies invested almost $5600m to ensure Cue Health could scale up production, FDA announces the self-administered test will be available OTC. it's the agency's first emergency use authorization for an at-home molecular diagnostic test available nonprescription.
Tezepelumab was among four products that the European Medicines Agency most recently considered for review under its accelerated assessment mechanism.
Korea’s Alteogen believes that formulation patents granted in the EU, US and Japan as well as a pending process patent may offer it a first-mover advantage on biosimilar aflibercept. The firm has just completed a Phase I trial for its proposed rival to Eylea.